Prime Medicine (PRME) Revenue & Revenue Breakdown
Prime Medicine Revenue Highlights
Prime Medicine Revenue by Period
Prime Medicine Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $5.21M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $5.21M | 100.00% |
| 2019-12-31 | - | - |
Prime Medicine generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Prime Medicine Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $591.00K | -97.70% |
| 2023-12-31 | $25.69M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $5.21M | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2019-12-31 | - | - |
Prime Medicine generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Prime Medicine Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RPRX | Royalty Pharma | $2.35B | $567.98M |
| BEAM | Beam Therapeutics | $377.71M | $11.77M |
| CRSP | CRISPR Therapeutics | $370.00M | $517.00K |
| DNA | Ginkgo Bioworks | $251.46M | $56.21M |
| BPMC | Blueprint Medicines | $249.38M | $128.18M |
| NTLA | Intellia Therapeutics | $36.27M | $6.96M |
| CRBU | Caribou Biosciences | $34.48M | $3.46M |
| RLAY | Relay Therapeutics | $25.55M | - |
| VERV | Verve Therapeutics | $11.76M | $5.70M |
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| LIFE | aTyr Pharma | $353.00K | $235.00K |
| EDIT | Editas Medicine | - | - |
| PRME | Prime Medicine | - | - |
| SANA | Sana Bio | - | - |
| OCEA | Ocean Biomedical | - | - |
| RPHM | Reneo Pharmaceuticals | - | - |
PRME Revenue FAQ
What is Prime Medicine’s yearly revenue?
Prime Medicine's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $5.21M, representing an increase of 100.00% compared to 2021. PRME's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.
What is Prime Medicine’s quarterly revenue?
Prime Medicine's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $591K, a -97.70% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). PRME's quarterly revenue for Q4 2023 was $25.69M, a 100.00% increase from the previous quarter (Q3 2023), and a 393.13% increase year-over-year (Q4 2022).
What is Prime Medicine’s revenue growth rate?
Prime Medicine's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.